Trial Profile
A Phase 1 Double-blind, Dose-escalation, Placebo-controlled Tolerance Study in Healthy Chinese Adults After Single Intravenous Administration of Dexlansoprazole
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Mar 2017
Price :
$35
*
At a glance
- Drugs Dexlansoprazole (Primary)
- Indications Erosive oesophagitis; Gastro-oesophageal reflux
- Focus Adverse reactions
- 15 Mar 2017 Status changed from not yet recruiting to completed.
- 10 Jan 2017 New trial record